Celularity Inc.: 10-Q filed 2021-05-24

Name: Celularity Inc.: 10-Q filed 2021-05-24
Creator: Celularity Inc.

What Celularity Inc. reported in its quarterly report filed 2021-05-24 (fiscal Q1 2021): 19 published measures, 39 facts as tagged in accession 0001213900-21-028857.

This filing

Form: 10-Q (quarterly report)
Filed: 2021-05-24
Fiscal period: fiscal Q1 2021
Accession: 0001213900-21-028857 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Celularity Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2021-03-31	291,927,576	USD
At 2020-12-31	292,156,433	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2021-03-31	39,765,155	USD
At 2020-12-31	78,022,974	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2021-03-31	-39,582,937	USD
At 2020-12-31	5,000,002	USD
At 2020-03-31	5,000,008	USD
At 2019-12-31	5,000,001	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2021-03-31	28,654	USD
At 2020-12-31	314,696	USD
At 2020-03-31	504,930	USD
At 2019-12-31	917,007	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2021-01-01 to 2021-03-31	38,028,962	USD	90
2020-01-01 to 2020-03-31	6,368,437	USD	91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2021-01-01 to 2021-03-31	-446,092	USD	90
2020-01-01 to 2020-03-31	-549,577	USD	91

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2021-01-01 to 2021-03-31	120,000	USD	90

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2021-01-01 to 2021-03-31	40,050	USD	90
2020-01-01 to 2020-03-31	137,500	USD	91

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2021-03-31	-39,583,656	USD
At 2020-12-31	-43,382,625	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2021-01-01 to 2021-03-31	-43,700	USD	90
2020-01-01 to 2020-03-31	272,639	USD	91

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2021-01-01 to 2021-03-31	-2,050,121	USD	90
2020-01-01 to 2020-03-31	-241,639	USD	91

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2021-03-31	99,501	USD
At 2020-12-31	359,289	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2021-03-31	5,160,155	USD
At 2020-12-31	3,409,872	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2020-12-31	48,381,093	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2021-03-31	-39,582,937	USD
At 2020-12-31	5,000,002	USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

Period	Value	Unit	Days
At 2020-12-31	602	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2021-01-01 to 2021-03-31	37,985,262	USD	90
2020-01-01 to 2020-03-31	6,641,076	USD	91

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2021-01-01 to 2021-03-31	40,035,383	USD	90
2020-01-01 to 2020-03-31	6,882,715	USD	91

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2021-01-01 to 2021-03-31	-43,700	USD	90
2020-01-01 to 2020-03-31	91,930	USD	91

Inspect the source

Entity: Celularity Inc. / CIK 0001752828
Captured: 2026-09-21T17:29:07.737Z
SEC response SHA-256: 732b52ad9f2d29e719fef49cad3d40c16039c1cb3073b05f4cf01eb23c287447

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001752828.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))